Ankylosing spondylitis and psoriatic arthritis: revisiting screening of latent tuberculosis infection and its follow-up during anti-tumor necrosis factor therapy in an endemic area.
Andrea Yukie ShimabucoAna Cristina de Medeiros RibeiroRenata MiossiKarina Rossi BonfiglioliJulio Cesar Bertacini de MoraesCelio Roberto GonçalvesPercival Degrava Sampaio-BarrosCláudia Goldenstein-SchainbergFernando Henrique Carlos de SouzaLeandro Lara do PradoMichelle Remião Ugolini LopesEmily Figueiredo Vieira Neves YukiEloisa S BonfaCarla Gonçalves Schahin SaadPublished in: Clinics (Sao Paulo, Brazil) (2020)
Known re-exposure is the most critical factor for incident TB cases in spondyloarthritis. There are also some distinct features in AS and PsA LTBI screening, considering the higher frequency of LTBI and TST positivities in patients with AS. Annual risk reassessment taking into consideration these peculiar features and including the TST should be recommended for patients in endemic countries.
Keyphrases
- ankylosing spondylitis
- rheumatoid arthritis
- disease activity
- end stage renal disease
- mycobacterium tuberculosis
- prostate cancer
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- stem cells
- emergency department
- type diabetes
- peritoneal dialysis
- mesenchymal stem cells
- bone marrow
- patient reported outcomes
- human immunodeficiency virus